Cargando…
Thanks to Our Reviewers in 2022
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108554/ http://dx.doi.org/10.1093/abt/tbad005 |
| _version_ | 1785026872358207488 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10108554 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101085542023-04-18 Thanks to Our Reviewers in 2022 Antib Ther Editorial Oxford University Press 2023-03-24 /pmc/articles/PMC10108554/ http://dx.doi.org/10.1093/abt/tbad005 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Antibody Therapeutics. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Thanks to Our Reviewers in 2022 |
| title | Thanks to Our Reviewers in 2022 |
| title_full | Thanks to Our Reviewers in 2022 |
| title_fullStr | Thanks to Our Reviewers in 2022 |
| title_full_unstemmed | Thanks to Our Reviewers in 2022 |
| title_short | Thanks to Our Reviewers in 2022 |
| title_sort | thanks to our reviewers in 2022 |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108554/ http://dx.doi.org/10.1093/abt/tbad005 |